06622.HK_Providing professional financial news and data related to 06622.HK, committed to creating a comprehensive and efficient information access channel for users | NewTimeSpace

ZHAOKE OPHTH-B (06622.HK): Enters five-year exclusive distribution and promotion agreement with Pengpai Biomedical for Emedastine Hydrochloride Eye Drops across all sales channels in China

Tags：

ZHAOKE OPHTH-B 06622.HK strategic cooperation

2026-08-12

ZHAOKE OPHTH-B (06622.HK): Presbyopia Innovative Drug YUVEZZI™ Approved by Macao Drug Administration

Tags：

ZHAOKE OPHTH-B 06622.HK presbyopia

2026-07-20

ZHAOKE OPHTH-B (06622.HK): Acquires Global Rights to NVK002 (Atropine Sulfate Eye Drops) to Fully Control Paediatric Myopia Programme Development

Tags：

ZHAOKE OPHTH-B 06622.HK paediatric myopia

2026-07-13

ZHAOKE OPHTH-B(06622.HK): Presbyopia Innovative Drug YUVEZZI™ Approved for Urgent Clinical Import and Use at Boao Super Hospital

Tags：

ZHAOKE OPHTH-B 06622.HK breakthrough drug

2026-07-07

ZHAOKE OPHTH-B(06622.HK): Australia's TGA Accepts Registration Application for 0.02% Atropine Sulfate Eye Drops

Tags：

ZHAOKE OPHTH-B 06622.HK TGA

2026-06-15

Zhaoke Ophthalmology-B (06622.HK): Expands Collaboration Network to Advance Commercialization of Presbyopia New Drug BRIMOCHOL™ PF in Asian Markets

Tags：

Zhaoke Ophthalmology-B 06622.HK NewTimeSpace

2026-01-26

Scan QR Code

Download App